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(utcomes research is applied clinical and population-based
esearch that seeks to study and optimize the end results of
ealth care—that is, the experience of the patient and the
mpact on society. All studies have outcomes, but this
esearch is distinctive because of its focus on the end result
f what health care seeks to achieve for patients and society.
utcomes research is not defined by a particular method-
logy, but rather by its objective. The research can focus on
nderstanding current patterns of care, evaluating interven-
ions to improve care, or generating insights to improve
ecision making or health-care delivery.
This type of research is growing in importance. As
dvances in cardiovascular research over the last several
ecades have augmented our ability to prevent, diagnose,
nd treat heart disease, questions are increasingly being
aised about the dissemination of these strategies, their
ffectiveness in clinical practice, and their value to society.
linicians and patients are asking how various strategies
ffect people’s lives—not just how long they live but how
ell they live. Moreover, there is increasing concern about
he current quality of health care and how it may be
mproved.
Health-care delivery and outcomes research have been
ncreasingly represented in the published literature. This
verview highlights information from prominent health-
are delivery and outcomes research publications in 2003
nd early 2004. It would not be possible to include all the
oteworthy studies on this topic in a single review; thus, I
ave selected from among those with the most impact. The
ational Academy of Sciences Institute of Medicine (IOM)
dentified core goals for the future of American health care
hat include safety, effectiveness, equity, efficiency, timeli-
ess, and patient-centeredness. This review is aligned with
hose themes, substituting the broader category of quality of
are for safety and effectiveness.
QUITY
everal studies have addressed the issue of disparities in our
ealth-care system. Although equity in treatment should be
property of every health-care system, many experts have
From the Section of Cardiovascular Medicine and the Robert Wood Johnson
linical Scholars Program, Department of Internal Medicine, and the Department of
pidemiology and Public Health, Yale University School of Medicine; and the
ale-New Haven Hospital Center for Outcomes Research and Evaluation, New
aven, Connecticut.dManuscript received June 21, 2004; accepted July 2, 2004.aised concerns about whether gender, race/ethnicity, and
ocioeconomic status influence the provision of care and the
utcomes of patients. The findings of studies on this topic
re occasionally inconsistent, indicating a need for further
nvestigation. The highest impact studies addressed equity
ssues in the treatment of patients with ischemic heart
isease and heart failure. They also examined the use of
ardiac procedures.
Canada, with its universal health care, provides an op-
ortunity to assess equity in a system in which cost is not a
arrier to care. Two studies found that Canadian referral
atterns are associated with socioeconomic status. The
ocio-Economic Status and Acute Myocardial Infarction
SESAMI) study, a prospective, longitudinal, observational
tudy of patients hospitalized with acute myocardial infarc-
ion (AMI) in Ontario, Canada, found that affluent patients
ere more likely to be referred for coronary angiography,
ardiac rehabilitation, and to a cardiologist (1). Moreover,
ducation was a stronger determinant of specialty cardiac
are than was income. However, neither income nor edu-
ation was significantly associated with adjusted risk of
ortality at one year. In a study from Quebec, Canada,
nvestigators also documented differences in cardiac referral
ates for procedures after AMI by socioeconomic status (2).
he findings raise questions about the underlying cause of
he different referral patterns and whether they have any
mpact on long-term patient outcomes.
Several studies have addressed whether care and out-
omes vary by race/ethnicity. The findings seem to depend
n the population studied. Jha et al. (3) from the Heart and
strogen/progestin Replacement Study (HERS), a ran-
omized trial, investigated medical care and outcomes
mong black and white women with established coronary
rtery disease. Black women were less likely to receive
spirin after AMI (80% vs. 74%; p  0.1), beta-blockers
fter AMI (34% vs. 32%), and statins if low-density lipopro-
ein (LDL) was 100 mg/dl (35% vs. 26%), but those with
history of heart failure were more likely to receive an
ngiotensin-converting enzyme (ACE) inhibitor (36% vs.
6%). Black women were also more likely to have poorer
lood pressure and lipid control than were white women.
ver more than four years of follow-up, the black women
ad an adjusted 60% greater risk of coronary heart disease
CHD) events. Interestingly, the differences in treatment
id not explain the differences in outcome. After consider-
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azard was still 52% higher.
Investigators from the Atherosclerosis Risk In Commu-
ities (ARIC) study investigated racial/ethnic differences in
ortality after AMI in 471 white and 171 black patients
ithout a prior history of AMI. The crude mortality rate
as higher for blacks compared with whites (21% vs. 14%).
n contrast to the HERS, adjustment for demographics,
ascular risk factors, socioeconomic factors, and severity of
MI and treatment eliminated the difference by race/
thnicity.
In heart failure, it appears that black patients and women
ave a survival advantage. In a large, nationally representa-
ive study, Rathore et al. (4) evaluated the care and out-
omes of 29,732 black and white Medicare beneficiaries
ospitalized with heart failure from 1998 to 1999. This
tudy, based on detailed medical record review and con-
ucted with data from the Centers for Medicare and
edicaid Services, found that blacks were not disadvan-
aged in two key processes of care: 1) the evaluation of left
entricular ejection fraction (67.8% black vs. 66.6% white),
nd 2) ACE inhibitor use (81.0% black vs. 73.8% white).
lack patients had a lower risk of mortality at 30 days (6.3%
s. 10.7%) and 1 year (31.5% vs. 40.1%). After adjusting for
otential confounders, blacks had a 22% lower risk of death
t 30 days and a 7% lower risk at 1 year than whites, but
heir risk of readmission was 9% higher. The investigators
oncluded that the black patients did not appear to have
orse heart failure care. However, their higher readmission
ates raise concern.
Ghali et al. (5) from the Beta-blocker Evaluation of
urvival Trial (BEST) investigated gender differences
mong 593 men and 2,115 women with advanced heart
ailure. After adjusting for major factors related to mortality,
omen had a significant survival advantage over men.
urther analysis suggested that this advantage was restricted
o those who had a nonischemic etiology of heart failure.
he differences are provocative, but whether they are the
esult of biology, environment, health care, or chance has yet
o be determined.
The use of cardiac procedures by race/ethnicity and
ender continues to receive attention in the published
eports. Studies consistently find differences, but fall short of
roviding insight into the mechanism. Gillum (6) examined
rends during the 1990s in the use of coronary revascular-
zation by gender and race/ethnicity. Bypass surgery and
ngioplasty increased over the decade in all groups. Differ-
nces by race, as a percentage, were greater in the older age
roups and in women compared with men. The absolute
ifferences per 100,000 in the population remained rela-
ively constant. The underlying cause of these differences
as yet to be demonstrated—and there remains debate
bout whether this pattern represents underuse of one,
veruse of the other, or some combination.
The use of implantable cardioverter-defibrillators (ICDs)as appropriately drawn some scrutiny. Groeneveld et al. (7) Avaluated the rates of cardiac procedures among 5,429 white
nd 519 black patients who experienced a cardiac arrest.
he information was derived from Medicare billing data
rom 1990 to 1999 and used an admission diagnosis code of
entricular fibrillation or cardiac arrest. Although ICDs
ere equally effective in blacks and whites, blacks age 66 to
4 years had a 42% lower odds of receiving them. In
ddition, blacks in that age group had a 30% higher risk of
eath than whites.
ATIENT-CENTEREDNESS
here is increasing interest in assessing outcomes from
atients’ perspective, with particular interest in health status
nd quality of life. These studies have also sought to
nderstand some of the key determinants of health-status
utcomes. The advent of tools to measure health status has
apidly advanced this field of investigation.
Several studies have examined the impact of particular
actors on health-status outcomes. Two studies provided
nsight about the association of age with the health status of
atients undergoing cardiac surgery. Conaway et al. (8)
valuated the impact of age on recovery from bypass surgery
mong 690 consecutive patients, including 138 who were
lder than 75 years, admitted to the Mid America Heart
nstitute in Kansas City, Missouri. The improvement in
ngina frequency and physical functioning was similar in
ounger and older patients by six months.
Sedrakyan et al. (9) sought to determine the association
f age with the change in quality of life after valve surgery.
hey prospectively enrolled 126 patients with aortic and 60
atients with mitral valve surgery who completed baseline
nd follow-up questionnaires. All age groups experienced
mprovements in health status, demonstrating that age is
ot an important predictor of the change in health status
fter surgery.
A study by Vaccarino et al. (10,11) compared health-
tatus outcomes after bypass surgery in 804 men and 309
omen who underwent surgery at Yale-New Haven Hos-
ital. The mortality rate was similar in men and women. By
ight weeks after surgery, the readmission rate in women
as almost twice that in men (20.5% vs. 11.0%). Although
en had no change in their physical function by eight
eeks, women had, on average, a marked decline. By six
onths, although both men and women, on average, had
mproved physical functioning and mental health since
urgery, the men had improved much more than the
omen. Women did worse than men in rates of readmission
32.6% vs. 21.2%), declining functional status (25.7% vs.
1.1%), and declining mental health (17.5% vs. 12.6%).
his study demonstrates the importance of health-status
easurement, because an exclusive focus on mortality would
ave given a very different impression of the comparison
etween men and women.
Rumsfeld et al. (12) from the Department of Veteransffairs (VA) compared health-related quality of life for
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ary intervention or bypass surgery. The main trial reported
o mortality difference between the groups, and this analysis
dded that the type of revascularization was not associated
ith any of the health-status measurements. Significant
redictors of worse six-month physical health status were
hronic obstructive pulmonary disease, diabetes, and an
levated creatinine. This type of analysis is critically impor-
ant in providing more information about the impact of
hese strategies on the lives of patients.
Psychosocial factors, such as depressive symptoms, are
eing increasingly recognized as having an important im-
act on patients with cardiac disease. Rumsfeld et al. (13)
ssessed the impact of depressive symptoms on changes in
ealth status in heart-failure patients. A striking finding was
hat 30% of the 460 outpatients in their study had signifi-
ant depressive symptoms at baseline. Over approximately
ix weeks of follow-up, the patients with depressive symp-
oms were much more likely to experience a worsening of
heir heart-failure–specific health status. In another study
valuating the association of depressive symptoms in veter-
ns with angina, Rumsfeld et al. (14) found a high preva-
ence of depressive symptoms and a strong association with
orse health status after a hospitalization for AMI or
nstable angina. Strik et al. (15) examined depression and
nxiety as predictors of cardiac events after an AMI.
tudying 318 men over a period of 3.4 years, they found that
oth anxiety and depression were strongly associated with
he risk of events, and anxiety appeared to mediate some of
he risk associated with depressive symptoms. Although
ast interventions have been disappointing, these studies
upport further attempts to modify psychosocial factors as a
eans of improving outcomes in cardiac patients.
IMELINESS/ACCESS
nother important goal of the health-care system is time-
iness and access to care. Few studies have focused on the
imeliness of care, particularly the prevalence and impact of
elays that are inherent in the health-care system. Reports
n access have specifically addressed specialty care and its
mpact on outcomes.
Many patients admitted with cardiac conditions do not
eceive care from a cardiologist. Foody et al. (16), using a
ationally representative sample of Medicare patients hos-
italized with heart failure, found that only about half of the
atients received treatment from a cardiologist, and only
ne quarter had a cardiologist as their attending physician.
lder patients and women were less likely to have a
ardiologist as an attending physician, but race was not a
ignificant factor.
The value of specialty care, however, remains controver-
ial. Several studies in the past year have suggested that
ardiology care is associated with better treatment and
utcomes. Ansari et al. (17), using data from the California
aiser Permanente Medical Care Program, found that bardiology participation in the care of patients with heart
ailure was associated with a higher likelihood of having had
n ejection fraction measurement and having been pre-
cribed ACE inhibitors and beta-blockers. Cardiology care
as also associated with a substantially lower adjusted risk of
eath or cardiovascular hospitalization (hazard ratio [HR]
.65; 95% confidence interval [CI] 0.45 to 0.96). Indridason
t al. (18), using a national Veterans Health Administration
atabase, found that cardiology care, or the combination of
ardiology care and general practitioner care, was associated
ith better survival than was general practitioner care alone.
ow this effect is mediated has yet to be determined.
Future studies in this domain may focus on the timeliness
f care and the impact on patient outcomes of delays in
iagnosis and treatment. Moreover, there is a need to
nderstand how the organization of care affects these
elays.
FFICIENCY
ith increasing health-care costs, growing interest has
risen in studies that provide information about patterns of
ealth-care spending and how best to allocate resources.
ore studies are needed that provide insight about how to
alance each patient’s needs with what society is willing to
rovide.
Perhaps the most important contributions in this area
ere offered by Fisher et al. (19,20) in a pair of classic
tudies examining the implications of regional variation in
edicare spending. In the first study, they investigated
everal conditions, including AMI, to determine whether
egions with higher spending delivered better care. They
ound marked differences in health-care spending across the
. S. In the last six months of life, spending by hospital
eferral region ranged from $9,074 in the lowest quintile to
14,644 in the highest quintile. Regions that spent more
oney provided more care, but they did not have lower
ortality rates. Regions with higher expenditures did not
rovide higher-quality care. Functional status and satisfac-
ion with care also did not improve with higher spending.
hese studies fail to show any benefit associated with the
igher-spending regions. The researchers report that sub-
tantial sums could be saved if the nation at large could
each the levels achieved by the regions with the lowest
ecile of spending.
Many of the notable studies provided economic analyses
f specific clinical strategies. These studies used cost-
ffectiveness analysis to compare alternative strategies.
The value of B-type natriuretic peptide (BNP) as a
creening strategy has received attention. Heidenreich et al.
21) investigated the cost-effectiveness of screening patients
ith BNP to identify those with depressed left-ventricular
ystolic function. They reported that the test was econom-
cally attractive for many populations. Among men age 60
ears with no evidence of heart failure, screening (followed
y echocardiography if the BNP test was abnormal) cost
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o screening. The BNP strategy required 44 people to be
creened to detect one person with a depressed ejection
raction and 127 to gain one quality-adjusted life-year. For
omen age 60 years, it cost $77,700 to gain a quality-
djusted life-year. In sensitivity analyses, the investigators
ound that screening was attractive for patient groups with
t least a 1% prevalence of left ventricular systolic dysfunction.
The success of public defibrillation has led investigators
o consider the value of various strategies of employing this
pproach. Nichol et al. (22) evaluated the cost-effectiveness
f defibrillation by targeted nontraditional responders in
ublic settings (using casinos as the base case). Compared
ith emergency medical services, targeted nontraditional
esponders cost $56,700 per quality-adjusted life-year.
ublic-access defibrillation was not economically attractive
f the incidence of arrest was rare, if the time to defibrillate
y nontraditional responders was long, or if responders were
ompensated while being trained. Walker et al. (23) also
ddressed this issue using data from the Scottish Ambulance
ervice. They considered the placement of defibrillators in
ajor airports, railway stations, and bus depots. The public
efibrillator strategy cost £41,146 per quality-adjusted life-
ear saved. These reports suggest that the judicious place-
ent of these devices in high-risk areas is an attractive
nvestment from society’s perspective.
With the expansion of options for the diagnosis and
reatment of ischemic heart disease, many payers are seeking
conomic analyses to justify clinical strategies. Recently,
everal notable studies addressed this issue, but there is a
lear need for more work in this area.
Bakhai et al. (24), from the Controlled Abciximab and
evice Investigation to Lower Late Angioplasty Compli-
ations (CADILLAC) trial, assessed the cost-effectiveness
f stenting and glycoprotein (GP) IIb/IIIa inhibition for
atients undergoing primary angioplasty. Stenting cost an
dditional $11,237 for each quality-adjusted life-year. In
ontrast, anticoagulation was an economically dominant
trategy (lower long-term costs and greater quality-adjusted
ife expectancy) compared with GP IIb/IIIa inhibition.
hus, stenting seemed worth the investment, but the value
f GP IIb/IIIa inhibition could not be justified.
Lamy et al. (25) investigated the cost implications of the
eart Outcomes Prevention Evaluation (HOPE) study, a
andomized trial of ramipril versus placebo among patients
ho were at least 55 years of age and had high-risk
haracteristics, but who were not known to have heart
ailure or a depressed ejection fraction. They found that the
ifference in costs between the two treatment groups ranged
rom $734 to $512 in the U. S. and $269 to $497 in
anada. Thus, the increased cost of ramipril was offset by
he reduction in cardiac events.
The measurement of fractional flow reserve is growing,
ut whether its cost is worth the benefit was studied last year
y Fearon et al. (26), who compared the following strate-
ies: deferring the decision for percutaneous coronary inter- aention to obtain a nuclear stress test; measuring fractional
ow reserve to guide the decision for percutaneous coronary
ntervention; and stenting all intermediate lesions. Quality-
djusted survival was the same for all three strategies. The
ractional flow reserve strategy saved $1,795 per patient
ompared with the nuclear testing strategy and $3,830
ompared with the stenting strategy.
Efficiency is also measured in other ways. Kaul et al. (27)
ade use of data from several international randomized
rials to assess trends in length of hospital stay and the
requency of early discharge of low-risk patients. Based on
ata from the Global Utilization of Streptokinase and
issue plasminogen activator for Occluded coronary arteries
GUSTO-I), the Global Use of Strategies To Open oc-
luded coronary arteries (GUSTO-III), and the Assessment
f the Safety and Efficacy of a New Thrombolytic
ASSENT-2) trials, they documented marked international
ariation in length of hospital stay. Overall, 40% of
atients eligible for early discharge were sent home on or
efore the fourth hospital day. In particular, the European
ountries had longer length of stay and fewer early dis-
harges of low-risk patients. Based on the extended stay of
ow-risk patients, Kaul et al. (27) calculated the number of
ospital days lost per 100 patients enrolled ranged from 91
n the U.S. to 738 days in Poland. This study highlights
otential waste that exists in all systems.
The hospital utilization issue was also examined with the
A medical-care system, where several initiatives to reduce
ospital care were implemented in the mid-1990s. For heart
ailure, adjusted bed-days per patient-year decreased from
8.7 in 1994 to 10.6 in 1998. The average length of hospital
tay decreased from 11.0 to 8.4 days. For angina, adjusted
ed-days per patient-year decreased from 8.7 in 1994 to 4.4
n 1998. The average length of stay decreased from 8.3 to
.3 days. The one-year survival rates for these patients
howed statistically significant annual improvement be-
ween 1994 and 1998. Among Medicare-eligible patients,
he drop in the use of VA hospitals was not associated with
n increase in the use of non-VA hospitals.
Some studies addressed burden of disease and priorities
or the future. Ezzati and Lopez (28) estimated that
moking caused almost five million premature deaths in
000. In industrialized countries, smoking accounts for 19%
f total adult mortality; in developing countries it accounts
or 9% of total adult mortality. In another study, Fontaine et
l. (29) estimated that severe obesity may reduce life
xpectancy by as much as 22%. Peeters et al. (30), in a
eparate analysis, also estimated large decrements in life
xpectancy that are associated with obesity. These studies
dentify where preventive strategies could have the most
enefit. Murray et al. (31) evaluated the value of many
reventive interventions. They found that nonpersonal
ealth interventions, such as government action to limit salt
ontent of processed food, are a very economically attractive
pproach in reducing cardiovascular disease. Personal inter-
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isk, rather than their measured blood pressure or choles-
erol concentration.
UALITY OF CARE
uality of care remains an important topic in health-care
elivery. Some important studies provided perspective on
he gaps in health-care performance, whereas others tested
trategies to improve care.
One of the most important studies documented the gap
etween optimal care and what is being provided to patients
round the country. McGlynn et al. (32) from RAND
eported on the quality of care delivered to adults in the
. S. based on telephone interviews and medical record
eview. Guideline-recommended treatment was commonly
ot provided overall or specifically for cardiac conditions.
he percentage of recommended care received was 68% for
oronary artery disease, 65% for hypertension, and 64% for
eart failure.
Several studies specifically examined preventive cardiol-
gy practices. Ford et al. (33) used data from the National
ealth And Nutrition Examination Survey (NHANES),
onducted in 1999 and 2000, to evaluate the awareness,
reatment, and control of hypercholesterolemia. Among
articipants who had an elevated cholesterol level or were
sing cholesterol-lowering medication, only 35% were
ware that they had hypercholesterolemia, 12% were under-
oing treatment, and 5.4% had a total cholesterol level
nder 200 mg/dl. Hajjar and Kotchen (34) performed a
imilar analysis with hypertension, and they found that
etween 1999 and 2000, 69% of the patients studied were
ware of their hypertension, 58% were treated, and 31%
ere controlled.
On a more optimistic note, Jha et al. (35) investigated the
uality of care within the VA health-care system during a
ime of system reengineering to improve treatment. From
994 to 2000 there were marked improvements in treat-
ent. Blood pressure control increased from 25% to 46%;
MI indicators also improved, including aspirin (89% to
8%) and beta-blockers (70% to 98%). In 2000, ACE
nhibitor use was 90% for AMI and 93% for heart-failure
atients. This study demonstrates the marked improve-
ents that can be achieved.
The issue of appropriateness of procedures is difficult to
pproach, but Petersen et al. (36) sought to determine the
revalence and impact of underuse of angiography in the
A health-care system in comparison with the Medicare
opulation. They found underuse, based on recommenda-
ions from clinical-practice guidelines, among the 1,665
eterans from 81 VA hospitals and the 19,305 Medicare
atients from non-VA hospitals. Among those with strong
ndications for angiography, it was performed on 44% of the
eterans and 51% of the Medicare patients. This difference
ersisted even after adjustment for potential confounders. eortality was similar in both groups, which raises questions
bout the definition of appropriateness.
Several studies tested interventions to improve care. In an
nnovative trial, Ferguson et al. (37) from the Society of
horacic Surgeons randomized 359 institutions to a con-
inuous quality-improvement intervention to increase the
se of preoperative beta-blockers and internal mammary
rtery grafting. The intervention group received a call to
ction to a physician leader, educational products, and
eriodic nationally benchmarked, site-specific data. The
ntervention was associated with a modestly significant
ncrease in the beta-blocker group (a 7.3% increase in the
ntervention compared with 3.6% in the control) and a trend
n the internal mammary artery group (increase of 8.7% in
he intervention compared with 5.4% in the control group).
Ansari et al. (38) evaluated computer reminders and
urse-facilitators to improve the use of beta-blockers for
atients with heart failure and depressed systolic function.
hey randomized 74 providers and found that the nurse-
acilitator group performed much better, initiating or titrat-
ng beta-blockers in more than 60% of the subjects com-
ared with one-third of those in the computer-reminder
nd control groups. The study is notable for showing the
neffectiveness of the computer reminders and the gaps in
uality even with the involvement of nurse-facilitators.
Murchie et al. (39) evaluated the effect of nurse-based
linics in primary care on secondary prevention of cardio-
ascular disease. Over almost four years of follow-up, the
ntervention group fared better with regard to aspirin use,
lood pressure and lipid management, the use of moderate
xercise, and a low-fat diet. The intervention was associated
ith a significant reduction in total mortality (HR 0.75;
5% CI 0.58 to 0.98).
In contrast to the studies that found nurse intervention to
e beneficial, Lichtman and colleagues discovered that an
ngoing nurse-based telephonic educational intervention
as not effective in improving compliance with lipid guide-
ines (40). They randomized 375 patients to the interven-
ion and 381 patients to usual care. After one year, no
ifference was seen in the proportion of patients who
eached target LDL levels.
Volume relationships with outcome were a contentious
ssue. Several organizations have used volume as a proxy for
uality, and a number of groups tested that assumption.
annan et al. (41) emphasized the continuing relationship
etween volume and outcome for bypass surgery in New
ork State. Peterson et al. (42), however, found that volume
as only weakly related to outcome for bypass surgery across
he country, and was not a good proxy for outcomes.
olume does not discriminate well between institutions,
nd having high volume does not guarantee good perfor-
ance. Rathore et al. (43), using a different national
atabase, reached the same conclusion. Birkmeyer et al. (44)
urther undermined the value of institution volume by
uggesting that surgeon volume accounted for 100% of the
ffect for aortic-valve replacement, 57% for elective repair of
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ypass grafting.
Other studies investigated key success factors for improv-
ng quality in hospitals. Holmboe et al. (45) focused on the
ole of physicians as leaders of quality improvement teams.
hey highlighted personal commitment; professional cred-
bility, quality improvement behaviors and skills, and insti-
utional linkages as important to the success of these
hysicians. Bradley et al. (46) identified the important
spects of data feedback, determining that it is most
ffective if it is perceived as valid, if it is timely, if it can be
ompared with other institutions, and if it is provided in a
egular and consistent manner.
UTURE DIRECTIONS
he importance of outcomes research is growing. The
rofession is challenged to provide care that is safe, effective,
fficient, equitable, timely, and patient-centered. There is
rowing recognition of the need for a broad base of evidence
o guide clinical decision making in the real world and to
uide policies that will enhance, not degrade, the care as
iewed from our patients’ perspective. Recently, more than
50 abstracts were presented at the 5th Annual American
eart Association/American College of Cardiology Scien-
ific Forum on Quality of Care and Outcomes Research in
ardiovascular Disease and Stroke. A Working Group of
he National Heart, Lung, and Blood Institute will soon
ublish recommendations about research priorities in this
eld. In the past year many important studies in outcome
esearch informed clinicians and policymakers. The expec-
ation is that this area of investigation, so closely tied to
linical practice and public health, is just beginning a rapid
rowth phase that will coincide with the needs of both the
rofession and society at large for information about how
est to deliver care.
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